about
Oxygen sensing in retinal health and diseaseRisk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical dataDexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trialThe expanding role of vascular endothelial growth factor inhibitors in ophthalmology.Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting.The ABCs of RVO: a review of retinal venous occlusion.Effects of arteriolar constriction on retinal gene expression and Müller cell responses in a rat model of branch retinal vein occlusion.Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panelPharmacotherapy for treatment of retinal vein occlusion.Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity.Central retinal vein occlusion and pseudoexfoliation syndrome.Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.Anemia in a middle aged female with aortitis: a case report.Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in FranceInvestigations into localized re-treatment of the retina with a 3-nanosecond laser.CAPILLARY NETWORK ANOMALIES IN BRANCH RETINAL VEIN OCCLUSION ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusionMetastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenibLong-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Post-hypoxic constriction of retinal arterioles is impaired during nitric oxide and cyclo-oxygenase inhibition and in diabetic patients without retinopathy.Platelet activation by ADP is increased in selected patients with anterior ischemic optic neuropathy or retinal vein occlusion.Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.Comparison between "early" or "late" intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up.Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs.Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin.An interesting case of rubeosis iridis with neovascular glaucoma in a young patient.En-face optical coherence tomography angiography of neovascularization elsewhere in hemicentral retinal vein occlusion.Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.Effects of Dexamethasone Implant on Multifocal Electroretinography in Central Retinal Vein Occlusion.Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion.Diameter changes of retinal arterioles during acute hypoxia in vivo are modified by the inhibition of nitric oxide and prostaglandin synthesis.Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab-a pilot study.Risk of Ischemic Stroke, Hemorrhagic Stroke, and All-Cause Mortality in Retinal Vein Occlusion: A Nationwide Population-Based Cohort StudyAnalysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone ImplantPrevalence and risk factors of retinal vein occlusion: the Gutenberg Health StudyEffect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
P2860
Q26827518-8EE442D9-3611-42DB-A861-3C5669D7D4D5Q30835869-52D3D383-1DB1-4073-B5AA-132B06770F10Q31117687-2FC79BBD-D825-459F-BCF9-6E915E0FC423Q34115840-41092852-2E23-4F39-9573-7044FB2DB25BQ34293412-2AFB0EC4-EAA6-4998-8AE3-2CCEA57BA416Q35047634-4BE0067E-5F9C-44B2-8837-84D480DEE207Q35057237-9B2EADED-19F2-4FF7-960B-A433D0CF376DQ35068919-6DF615ED-1166-43B5-B9B5-0F124854CD9EQ35135745-2588834D-41D3-477D-9B04-9F1A2D9B9202Q35238943-F2C1AC0C-521C-4EB7-B3EA-DDF0660CCEE5Q35407942-5BB6530A-56BF-43AF-95AF-90E02AB86449Q35653158-69B4A178-39D3-4672-BE07-D10ECA65FAD8Q35764068-05929A81-8556-4753-810A-8CE37111A246Q35817852-2BBFF6AC-EE25-4CD8-9E0B-2202531F1FDEQ35914881-D9738AF3-4FE0-451E-B98C-31834E3DA300Q36048745-22FCA7BB-C6F9-4361-A280-6811E2DC418FQ36056327-7F7690AC-D0F9-4A29-8816-E105C1E9774AQ36266683-28260A4C-222E-4D1D-B5E4-D8672A628874Q36490483-E0123639-D6B1-4B90-B14C-8C335590FD92Q37376498-EA7072D9-09CD-4F36-8DC1-B0FC23380797Q37530866-679FA7CF-21A1-4478-899D-809DAC57CF71Q37627442-C41AE75C-62F5-48BC-AEFF-EDE973FD967BQ38373193-A84D3E53-70C2-45B7-9C37-B11BCA207E6AQ38918380-0F1A759B-2BAD-4AC8-B4C1-5EEEAD0B7ADAQ39160582-C563517D-1A7E-4503-AA4C-3F38B2B609B4Q40429268-15564D24-EF41-46F4-BF3C-43A70757CEE4Q41112170-229024FB-5FF8-4BBD-A041-54D93004D090Q41949426-1B853CA2-24F6-4E23-BF55-EC710516A6ADQ42004122-2F59A71C-4C53-4803-8691-5A4B62431FD9Q42607879-164853BE-40DF-4D10-B809-2954BBDBE3FBQ49224656-2D5E9678-72EC-43CF-A036-D308B14B7BC8Q49847644-BFCB99DC-3869-4AD9-9680-48F920D71B62Q50544079-BD60C93C-180D-444D-B7BD-248CEF043C7CQ51699047-CC031A02-0F41-4AEA-87B2-8B7B2AD6A9E4Q55073223-DA6C8533-8F5F-44C4-8F2D-1471EB63D937Q57115836-C6E28B73-969A-44DE-95D9-F9711AA836ABQ57115851-78D0FDD5-65DE-4FEA-A088-101A5B747FD9Q58384451-6E4B043A-3685-4D4A-8BBD-D19B270A9FD9Q58765745-C6BD66B0-4DE8-449C-A221-942D1C08F3C3
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Retinal vein thrombosis: pathogenesis and management.
@ast
Retinal vein thrombosis: pathogenesis and management.
@en
Retinal vein thrombosis: pathogenesis and management.
@nl
type
label
Retinal vein thrombosis: pathogenesis and management.
@ast
Retinal vein thrombosis: pathogenesis and management.
@en
Retinal vein thrombosis: pathogenesis and management.
@nl
prefLabel
Retinal vein thrombosis: pathogenesis and management.
@ast
Retinal vein thrombosis: pathogenesis and management.
@en
Retinal vein thrombosis: pathogenesis and management.
@nl
P2860
P1476
Retinal vein thrombosis: pathogenesis and management.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2010.03909.X
P577
2010-09-01T00:00:00Z